BONVIVA

This brand name is authorized in Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug BONVIVA contains one active pharmaceutical ingredient (API):

1	Ibandronic acid UNII J12U072QL0 - IBANDRONATE SODIUM
	Ibandronic acid belongs to the bisphosphonate group of compounds which act specifically on bone. Their selective action on bone tissue is based on the high affinity of bisphosphonates for bone mineral. Bisphosphonates act by inhibiting osteoclast activity, although the precise mechanism is still not clear. In vivo, ibandronic acid prevents experimentally-induced bone destruction caused by cessation of gonadal function, retinoids, tumours or tumour extracts.
	Read more about Ibandronic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BONVIVA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M05BA06	Ibandronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	559118100008817
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00607239, 00607245, 02159124, 02484999, 02512402, 02512425, 03679699, 04113936, 04188584, 04188590, 05485025, 05485031, 05502373, 06089202, 06092693, 06326234, 06458102, 06494380, 06735079, 06786651, 06864983, 07123390, 07507050, 09013352, 10044613, 10535920, 10989822, 11183216, 11566147, 12432609, 15266471, 16706274, 16733288
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.340-11-06, 27.595-1-03-12
EE	Ravimiamet	1213209, 1213210, 1364688, 1364699
ES	Centro de información online de medicamentos de la AEMPS	03265003
FR	Base de données publique des médicaments	63460631, 68419617
GB	Medicines & Healthcare Products Regulatory Agency	102684, 138372, 142881, 198665, 375948, 95450
HK	Department of Health Drug Office	54056, 55745
IE	Health Products Regulatory Authority	13295, 13985, 13990, 14017, 14021, 14033
IT	Agenzia del Farmaco	036899019, 039672011, 044050019, 044424012
JP	医薬品医療機器総合機構	3999040F1026, 3999438G1027
LT	Valstybinė vaistų kontrolės tarnyba	1004721, 1004722, 1004771, 1027746
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	020M2005, 080M2003
NL	Z-Index G-Standaard, PRK	79685, 80675
PL	Rejestru Produktów Leczniczych	100140577, 100159134
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66028001
SG	Health Sciences Authority	13206P, 13328P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699543091808, 8699543091860, 8699543950013, 8699543950020